http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101090742-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B40-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate | 2008-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101090742-B1 |
| titleOfInvention | A marker for diagnosing lung cancer susceptibility using the HE-2 gene and a method for diagnosing lung cancer susceptibility using the same |
| abstract | The present invention relates to a marker for diagnosing lung cancer susceptibility that enables the prediction and selection of lung cancer risk, more specifically -3444C> T, -1985 G> T, P1170A C, which is a single nucleotide polymorphism (SNP) of a newly discovered gene. The present invention relates to a marker for diagnosing lung cancer susceptibility using G, a diagnostic kit, and a method for predicting and diagnosing lung cancer susceptibility using the same.n n n According to the present invention, it is possible to predict and select whether a patient group belongs to a high risk group of lung cancer carcinogenesis, and thus it can be usefully used for early diagnosis and treatment of lung cancer.n n n n Lung cancer, HER-2, single nucleotide polymorphism (SNP), haplotype |
| priorityDate | 2008-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.